Synthetic Peptide Vaccines: Success at Last

Vaccines ◽  
1995 ◽  
pp. 127-133 ◽  
Author(s):  
R. H. Meloen ◽  
J. I. Casal ◽  
K. Dalsgaard ◽  
J. P. M. Langeveld
Vaccine ◽  
1996 ◽  
Vol 14 (14) ◽  
pp. 1313-1321
Author(s):  
Sheue Ching T. Yu ◽  
Bishwajit Nag

Hepatitis B ◽  
1984 ◽  
pp. 215-224 ◽  
Author(s):  
G. R. Dreesman ◽  
I. Ionescu-Matiu ◽  
Y. Sanchez ◽  
R. C. Kennedy ◽  
J. T. Sparrow ◽  
...  

2011 ◽  
Vol 57 (1) ◽  
pp. 14-30 ◽  
Author(s):  
A.A. Moysa ◽  
E.F. Kolesanova

This review considers the stages of the development of synthetic peptide vaccines against infectious agents, novel approaches and technologies employed in this process, including bioinformatics, genomics, proteomics, large-scale peptide synthesis, high-throughput screening methods, the use of transgenic animals for modelling human infections. An important role for the development and selection of efficient adjuvants for peptide immunogens is noted. Examples of synthetic peptide vaccine developments against three infectious diseases (malaria, hepatitis C, and foot-and-mouth disease) are given.


2007 ◽  
Vol 6 (4) ◽  
pp. 591-603 ◽  
Author(s):  
Martijn S Bijker ◽  
Cornelis JM Melief ◽  
Rienk Offringa ◽  
Sjoerd H van der Burg

Vaccine ◽  
1995 ◽  
Vol 13 (10) ◽  
pp. 885-886 ◽  
Author(s):  
R.H. Meloen ◽  
J.I. Casal ◽  
K. Dalsgaard ◽  
J.P.M. Langeveld

1986 ◽  
Vol 137 ◽  
pp. 513-514 ◽  
Author(s):  
A.R. Neurath ◽  
S.B.H. Kent

2009 ◽  
Vol 50 (5) ◽  
pp. 357-364 ◽  
Author(s):  
NICO J.C.M. BEEKMAN ◽  
WIM M.M. SCHAAPER ◽  
GODEFRIDUS I. TESSER ◽  
KRISTIAN DALSGAARD ◽  
SØREN KAMSTRUP ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document